默沙东表示,总生存期数据目前尚未成熟,不过在Intismeran与Keytruda的联合疗法中,已观察到总生存期呈现出有利的走势。
默沙东表示,总生存期数据目前尚未成熟,不过在Intismeran与Keytruda的联合疗法中,已观察到总生存期呈现出有利的走势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.